APA (7th ed.) Citation

Butrón‐Bris, B., Llamas‐Velasco, M., Ovejero‐Benito, M. C., Santos‐Juanes, J., Martínez‐López, A., Ruiz‐Villaverde, R., . . . Daudén, E. (2024). Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real‐life clinical practice. Experimental Dermatology, 33(8), 1. https://doi.org/10.1111/exd.15152

Chicago Style (17th ed.) Citation

Butrón‐Bris, B., et al. "Genetic Polymorphisms to Identify Patients with an Optimal Response to Tildrakizumab in Psoriasis Patients from Real‐life Clinical Practice." Experimental Dermatology 33, no. 8 (2024): 1. https://doi.org/10.1111/exd.15152.

MLA (9th ed.) Citation

Butrón‐Bris, B., et al. "Genetic Polymorphisms to Identify Patients with an Optimal Response to Tildrakizumab in Psoriasis Patients from Real‐life Clinical Practice." Experimental Dermatology, vol. 33, no. 8, 2024, p. 1, https://doi.org/10.1111/exd.15152.